Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms
OrthoEvidence Journal (OE Journal) - ACE Report
OE Journal. 2022;10(12):42 Sci Rep. 2017 11-Apr;():. 10.1038/s41598-017-13282-7What this means for my practice?
Psilocybin, when used in patients with treatment-resistant depression, appears to reduce depressive symptoms. Imaging indicates that these decreased symptoms correlate with changes in blood flow and resting-state connectivity within several networks in the brain.
Study Summary
A case series comparing pre and post-treatment with psilocybin was conducted in 19 patients with treatment-resistant depression. Patients were assessed on the the Quick Inventory of Depressive Symptomology-Self Report (QIDS-SR16) before and after treatment, and also underwent fMRI to examine resting-state functional connectivity. All participants showed decreased depressive symptoms at 1 week, with 47% reaching criteria for being responders at 5 weeks. Whole brain analysis showed decreased cerebral blood flow in the temporal cortex, including the amygdala, with decreased amygdala blood flow being correlated with reduced depressive symptoms. Resting state functional connectivity was predictive of response at 5-weeks, with increases in ventromedial prefrontal cortex-bilateral inferior lateral parietal cortex connectivity and decreases in parahippocampal-prefrontal cortex connectivity predicting a responder.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
Are you affiliated with one of our partner associations?
Click here to gain complimentary access as part your association member benefits!
0 of 4 monthly FREE articles unlocked
